Monthly Archives: April 2019

Amgen Inc (AMGN) Receives a Buy from Oppenheimer

Oppenheimer analyst Jay Olson maintained a Buy rating on Amgen Inc (AMGN – Research Report) yesterday and set a price target of $220. The company’s shares closed yesterday at $179.32. Olson observed: “1Q results included non-GAAP EPS of $3.56, ahead

Canaccord Genuity Maintains Their Buy Rating on GenMark (GNMK)

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on GenMark (GNMK – Research Report) yesterday and set a price target of $10. The company’s shares closed yesterday at $7.24. Massaro commented: “We are positive on the hire of the

Oppenheimer Sticks to Its Buy Rating for Community Health (CYH)

In a report released yesterday, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Community Health (CYH – Research Report), with a price target of $5. The company’s shares closed yesterday at $3.44. Wiederhorn noted: “CYH reported Q1:19 adj-EBITDA of

Hubbell B (HUBB) Receives a Hold from Oppenheimer

Oppenheimer analyst Christopher Glynn maintained a Hold rating on Hubbell B (HUBB – Research Report) yesterday. The company’s shares closed yesterday at $127.60. Glynn said: “Organic growth was 5% including 2 months of faster growing Aclara in the organic base.

Oppenheimer Maintains a Hold Rating on Jack Henry & Associates (JKHY)

Oppenheimer analyst Glenn Greene maintained a Hold rating on Jack Henry & Associates (JKHY – Research Report) yesterday. The company’s shares closed yesterday at $149.06. Greene noted: “JKHY reported solid in-line 3QFY19 results with revenue and EPS both directionally comparable

Arconic Inc (ARNC) Receives a Hold from Cowen & Co.

Cowen & Co. analyst Gautam Khanna maintained a Hold rating on Arconic Inc (ARNC – Research Report) yesterday and set a price target of $24. The company’s shares closed yesterday at $21.48. According to TipRanks.com, Khanna is a 5-star analyst